Guggenheim Capital LLC Trevena Inc Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$1.44 - $2.24 $18,593 - $28,922	-12,912 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$1.51 - $2.06 $715 - $976	-474 Reduced 3.54%	12,912 $21,000
Q4 2017 Feb 14, 2018	SELL	$1.4 - $2.6 $2,331 - $4,329	-1,665 Reduced 11.06%	13,386 $22,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.79 $33,413 - $41,992	15,051	15,051 $38,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $1.15B
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.